228 related articles for article (PubMed ID: 20943071)
1. Etanercept therapy in patients with psoriasis and concomitant HCV infection.
Garavaglia MC; Altomare G
Int J Immunopathol Pharmacol; 2010; 23(3):965-9. PubMed ID: 20943071
[TBL] [Abstract][Full Text] [Related]
2. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
Zanni M; Missale G; Santilli D; Di Nuzzo S
Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients.
Costa L; Caso F; Atteno M; Giannitti C; Spadaro A; Ramonda R; Vezzù M; Del Puente A; Morisco F; Fiocco U; Galeazzi M; Punzi L; Scarpa R
Clin Rheumatol; 2014 Feb; 33(2):273-6. PubMed ID: 23975363
[TBL] [Abstract][Full Text] [Related]
4. Erythrodermic Psoriasis and Hepatitis C Infection Treated with Pegylated Interferon and Anti-TNFα α(Etanercept) Therapy.
Talat H; Wahid Z; Feroz F; Sajid M
J Coll Physicians Surg Pak; 2017 Sep; 27(9):S77-S79. PubMed ID: 28969730
[TBL] [Abstract][Full Text] [Related]
5. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
[TBL] [Abstract][Full Text] [Related]
6. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
7. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
Magliocco MA; Gottlieb AB
J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
[TBL] [Abstract][Full Text] [Related]
11. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
[TBL] [Abstract][Full Text] [Related]
12. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
13. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.
Navarro R; Vilarrasa E; Herranz P; Puig L; Bordas X; Carrascosa JM; Taberner R; Ferrán M; García-Bustinduy M; Romero-Maté A; Pedragosa R; García-Diez A; Daudén E
Br J Dermatol; 2013 Mar; 168(3):609-16. PubMed ID: 22985451
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection.
Giannitti C; Benucci M; Caporali R; Manganelli S; Bellisai F; Sebastiani GD; Galeazzi M
Int J Immunopathol Pharmacol; 2009; 22(2):543-6. PubMed ID: 19505408
[TBL] [Abstract][Full Text] [Related]
15. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ
Lancet; 2000 Jul; 356(9227):385-90. PubMed ID: 10972371
[TBL] [Abstract][Full Text] [Related]
16. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
Cho YT; Chen CH; Chiu HY; Tsai TF
J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
18. Etanercept therapy in patients with autoimmunity and hepatitis C.
Khanna M; Shirodkar MA; Gottlieb AB
J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
[TBL] [Abstract][Full Text] [Related]
19. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
Linardaki G; Katsarou O; Ioannidou P; Karafoulidou A; Boki K
J Rheumatol; 2007 Jun; 34(6):1353-5. PubMed ID: 17552060
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
